{
    "2021-01-14": [
        [
            {
                "time": "",
                "original_text": "【权益变动】泰格医药(03347-HK)被摩根大通减持91.6343万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "摩根大通",
                        "减持",
                        "91.6343万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药现1笔大宗交易 共成交2,905.20万元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "2,905.20万元"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "出口型企业黑马频出，“双冠王”实至名归",
                "features": {
                    "keywords": [
                        "出口型企业",
                        "黑马",
                        "双冠王"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "出口型行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：Q4医药板块延续恢复态势 结构性机会突出",
                "features": {
                    "keywords": [
                        "医药生物",
                        "Q4",
                        "恢复态势",
                        "结构性机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金高比例持有股票名单",
                "features": {
                    "keywords": [
                        "北向资金",
                        "高比例持有",
                        "股票名单"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}